A review of lifestyle, metabolic risk factors and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma

A review of lifestyle, metabolic risk factors and blood-based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma

We aimed to review the epidemiologic literature examining lifestyle, metabolic risk factors, and blood-based biomarkers including multi-omics (genomics, proteomics, and metabolomics) and to discuss how these predictive markers can inform early diagnosis of pancreatic ductal adenocarcinoma (PDAC). A...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Pang, Y, Holmes, M, Chen, Z, Kartsonaki, C
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Wiley 2018

Míreanna comhchosúla

Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
de réir: Lau, Allison N, et al.
Foilsithe / Cruthaithe: (2021)

The T cell architecture of pancreatic ductal adenocarcinoma
de réir: Sivakumar, S, et al.
Foilsithe / Cruthaithe: (2019)

The T-cell architecture of pancreatic ductal adenocarcinoma
de réir: Sivakumar, S, et al.
Foilsithe / Cruthaithe: (2019)

Imaging p53 in pancreatic ductal adenocarcinoma
de réir: Koustoulidou, S
Foilsithe / Cruthaithe: (2017)

PKM2 is not required for pancreatic ductal adenocarcinoma
de réir: Danai, Laura V, et al.
Foilsithe / Cruthaithe: (2018)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
de réir: Wang, L, et al.
Foilsithe / Cruthaithe: (2015)

Identifying genes that are required for the maintenance of pancreatic ductal adenocarcinoma
de réir: Jenq, Harry
Foilsithe / Cruthaithe: (2013)

Imaging p53 in Pancreatic Ductal Adenocarcinoma (PDAC)
de réir: Koustoulidou, S, et al.
Foilsithe / Cruthaithe: (2016)

Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes
de réir: De Santiago, I, et al.
Foilsithe / Cruthaithe: (2019)

Immuno-phenotypes of Pancreatic Ductal Adenocarcinoma: Metaanalysis of transcriptional subtypes
de réir: De Santiago, I, et al.
Foilsithe / Cruthaithe: (2018)

Metabolic reprogramming of tumor-infiltrating myeloid cells conveys protection against pancreatic ductal adenocarcinoma
de réir: Sieow, Je Lin
Foilsithe / Cruthaithe: (2019)

Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma
de réir: Chung, Katherine Minjee, et al.
Foilsithe / Cruthaithe: (2021)

Mechanisms of cancer cell death: Therapeutic implications for pancreatic ductal adenocarcinoma
de réir: Pook, H, et al.
Foilsithe / Cruthaithe: (2021)

Consumption of nuts and seeds and pancreatic ductal adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition
de réir: Obón‐Santacana, M, et al.
Foilsithe / Cruthaithe: (2019)

The Interaction of pancreatic Cancer and Stellate Cells as a Mediator of Radiation Resistance in ductal Pancreatic Adenocarcinoma
de réir: Mantoni, T, et al.
Foilsithe / Cruthaithe: (2011)

CD44 SNP rs187115: A novel biomarker signature that predicts survival in resectable pancreatic ductal adenocarcinoma.
de réir: Stracquadanio, G, et al.
Foilsithe / Cruthaithe: (2016)

CRS and HIPEC for pancreatic ductal adenocarcinoma with peritoneal metastases: a case report
de réir: Amin-Tai, Hizami, et al.
Foilsithe / Cruthaithe: (2023)

Cancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma
de réir: Tian, Chenxi, et al.
Foilsithe / Cruthaithe: (2020)

A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma
de réir: Ligorio, Matteo, et al.
Foilsithe / Cruthaithe: (2018)

Developing a model of acid-driven evolution for Pancreatic Ductal Adenocarcinoma (PDAC)
de réir: Blaszczak, WZ
Foilsithe / Cruthaithe: (2022)

Immuno-SPECT imaging of aberrant p53 expression in pancreatic ductal adenocarcinoma
de réir: Alakonya, H
Foilsithe / Cruthaithe: (2023)

Manipulating regulatory T cells: is it the key to unlocking effective immunotherapy for pancreatic ductal adenocarcinoma?
de réir: Smith, H, et al.
Foilsithe / Cruthaithe: (2024)

PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
de réir: Dushek, O, et al.
Foilsithe / Cruthaithe: (2016)

Dynamic IL-6R/STAT3 signaling leads to heterogeneity of metabolic phenotype in pancreatic ductal adenocarcinoma cells
de réir: Blaszczak, W, et al.
Foilsithe / Cruthaithe: (2023)

Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas.
de réir: Couvelard, A, et al.
Foilsithe / Cruthaithe: (2005)

A microenvironment-inspired synthetic three-dimensional model for pancreatic ductal adenocarcinoma organoids
de réir: Griffith, Linda
Foilsithe / Cruthaithe: (2023)

Molecular therapeutics of pancreatic ductal adenocarcinoma:targeted pathways and the role of cancer stem cells
de réir: Stoica, A, et al.
Foilsithe / Cruthaithe: (2020)

A pilot study of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC)
de réir: Chan, Kai Siang, et al.
Foilsithe / Cruthaithe: (2022)

BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma
de réir: Feng, Y, et al.
Foilsithe / Cruthaithe: (2023)

Conditional knockout of hypoxia-inducible factor 1-alpha in tumor-infiltrating neutrophils protects against pancreatic ductal adenocarcinoma
de réir: Sieow, Je Lin, et al.
Foilsithe / Cruthaithe: (2023)

The COVID-19 pandemic is associated with reduced survival after pancreatic ductal adenocarcinoma diagnosis: A single-centre retrospective analysis
de réir: Madge, O, et al.
Foilsithe / Cruthaithe: (2022)

Metabolic and lifestyle risk factors for acute pancreatitis in Chinese adults: A prospective cohort study of 0.5 million people
de réir: Pang, Y, et al.
Foilsithe / Cruthaithe: (2018)

DNA–SWCNT Biosensors Allow Real-Time Monitoring of Therapeutic Responses in Pancreatic Ductal Adenocarcinoma
de réir: Gong, Xun, et al.
Foilsithe / Cruthaithe: (2020)

Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic.
de réir: Fokas, E, et al.
Foilsithe / Cruthaithe: (2015)

Suppression of the Ubiquitin Ligase Function of FBXW7 Accelerates Metastatic Progression of Pancreatic Ductal Adenocarcinoma
de réir: Cervantes Jaramillo, Grissel
Foilsithe / Cruthaithe: (2023)

Suppression of pancreatic ductal adenocarcinoma growth and metastasis by fibrillar collagens produced selectively by tumor cells
de réir: Tian, Chenxi, et al.
Foilsithe / Cruthaithe: (2021)

The role of YAP and cell of origin during the progression of pancreatic neoplastic lesions to invasive ductal adenocarcinoma
de réir: Thapa, A
Foilsithe / Cruthaithe: (2020)

Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case–control study
de réir: Tan, PS, et al.
Foilsithe / Cruthaithe: (2022)

Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
de réir: Olivares, Orianne, et al.
Foilsithe / Cruthaithe: (2018)

Role of carbonic anhydrase catalysis and gap junctional coupling in regulating ph in pancreatic ductal adenocarcinoma (PDAC)
de réir: Dovmark, T
Foilsithe / Cruthaithe: (2017)